October 16, 2020 —
Dr. Collins and NCATS Director Dr. Christopher Austin host a Q&A on the latest clinical trial launched as part of NIH’s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership.
October 16, 2020 —
Dr. Collins provides an update on COVID-19 vaccines and therapeutics and details the levels of review for a vaccine to meet safety and efficacy standards.
October 16, 2020 —
Dr. Collins covers a range topics related to COVID-19 including vaccine development and testing for safety and efficacy, wearing a face covering, large gatherings including the holidays, and more.
October 8, 2020 —
Dr. Collins speaks with Dr. Doudna about winning the 2020 Nobel Prize in Chemistry with Dr. Emmanuelle Charpentier for their work developing the gene-editing technology CRISPR.
October 5, 2020 —
Watch Dr. Collins speak with NIH researcher Dr. Harvey J. Alter, recipient of the 2020 Nobel Prize in Physiology or Medicine for his contributions to the discovery of the hepatitis C virus.
September 24, 2020 —
Watch Dr. Collins, Dr. Fauci, & COVPN’s Dr. Michele Andrasik give an update on NIH COVID-19 vaccine research, including the Janssen Phase 3 vaccine clinical trial, & the importance of diversity in participants.
September 16, 2020 —
Dr. Collins talks to ABC’s Bob Woodruff about the COVID-19 vaccine candidates, vaccine safety standards, the potential timeline for vaccine distribution, and more.
September 12, 2020 —
During an interview with MSNBC’s Ali Velshi, Dr. Collins stresses that coronavirus vaccines being tested will be held to the highest standards for safety and efficacy.
September 10, 2020 —
In a CNN Town Hall interview, Dr. Collins covers a range of COVID-19-related topics including the importance of following safety guidance such as wearing a mask and social distancing, the timeline for a vaccine, and the Data and Safety Monitoring Board’s role in overseeing clinical trials.
September 10, 2020 —
In a live conversation on Facebook and Twitter, Dr. Collins and NHLBI Director Dr. Gary Gibbons discuss the launch of Phase 3 clinical trials to evaluate the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19.
